πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 255 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9243239

Purification of cystathionine beta-synthase

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9212212

Targeting complement factor H for treatment of diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9180196

Photodegradable groups for tunable polymeric materials

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9138383

Nanogel materials and methods of use thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9091701

Disease severity index for assessment of chronic liver disease and method for diagnosis of

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9084746

Therapeutic applications of SMAD7

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9073985

Methods and products for treating proliferative diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9067968

Tight junction protein modulators and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9062347

Endothelin single nucleotide polymorphisms and methods of predicting Ξ²-adrenergic receptor

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9034318

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9023984

Diagnostic and therapeutic target for autoimmune diseases and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9011844

Human cystathionine Ξ²-synthase variants and methods of production thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8992906

Compositions and methods for engraftment and increasing survival of adult muscle stem cell

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962709

Resin systems for dental restorative materials and methods using same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8957031

Competitive inhibitors of invariant chain expression and/or ectopic clip binding

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8937046

Modulating the alternative complement pathway

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8920799

Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosi

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916603

Methods for treatment with bucindolol based on genetic targeting

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8911733

Inhibition of the alternative complement pathway for treatment of traumatic brain injury,

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8911722

Modulation of yeast-based immunotherapy products and responses

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883189

Intraocular encapsulation of oxygenic bacteria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883144

Treatment of pulmonary vascular remodeling with neprilysin

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8858945

Three-dimensional structure of complement receptor type 2 and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8840868

Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticle

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted